Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Lytic Cycle of Bacteriophages

Lytic Cycle of Bacteriophages

Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

Lysogenic Cycle of Bacteriophages

Lysogenic Cycle of Bacteriophages

In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...

DNA Bacteriophages

DNA Bacteriophages

Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...

Viral Replication: Lysogenic Cycle

Viral Replication: Lysogenic Cycle

The lysogenic cycle is a crucial viral replication strategy that allows bacteriophages to persist within host cells without immediately destroying them. This process is primarily observed in temperate phages, such as bacteriophage lambda (λ), which infects Escherichia coli. The cycle allows the viral genome to persist across bacterial generations while keeping host cells viable.Integration of the Viral GenomeUpon infection, bacteriophage lambda attaches to the bacterial surface and injects...

Gene Therapy

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Advances and challenges in microbiome transplantation.

Cell host & microbe·2026

Same author

The interplay between the microbiome and immune cells in metabolic homeostasis and disease.

Cell metabolism·2026

Same author

Klebsiella genus as driver of human disease: from infections to non-communicable disorders.

Nature reviews. Microbiology·2026

Same author

Disruption of the brain-spleen axis impairs monocyte-microglia communication and accelerates disease progression in a mouse model of amyloidosis.

Nature communications·2026

Same author

Next-generation probiotics: an outlook into current applications and future developments.

Nature reviews. Microbiology·2026

Same author

Maternal antibodies regulate the establishment of murine oral and salivary mucosal immunity.

Nature communications·2026

Search research articles

Related Experiment Video

Updated: Jul 12, 2025

Phage Therapy Application to Counteract Pseudomonas aeruginosa Infection in Cystic Fibrosis Zebrafish Embryos

Phage Therapy Application to Counteract Pseudomonas aeruginosa Infection in Cystic Fibrosis Zebrafish Embryos

Published on: May 12, 2020

Phage therapy in noncommunicable diseases.

Denise Kviatcovsky¹, Rafael Valdés-Mas¹, Sara Federici¹

¹Systems Immunology Department, Weizmann Institute of Science, Rehovot, Israel.

Science (New York, N.Y.)

|October 19, 2023

Summary

Bacteriophages, viruses that infect bacteria, show promise in controlling harmful commensal bacteria. This research explores their potential to suppress bacteria linked to disease development.

More Related Videos

Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings

Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings

Published on: August 19, 2021

Author Spotlight: Investigating Bacteriophage-Induced Immune Responses in Gnotobiotic Mice

Author Spotlight: Investigating Bacteriophage-Induced Immune Responses in Gnotobiotic Mice

Published on: January 26, 2024

Related Experiment Videos

Last Updated: Jul 12, 2025

Phage Therapy Application to Counteract Pseudomonas aeruginosa Infection in Cystic Fibrosis Zebrafish Embryos

Phage Therapy Application to Counteract Pseudomonas aeruginosa Infection in Cystic Fibrosis Zebrafish Embryos

Published on: May 12, 2020

Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings

Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings

Published on: August 19, 2021

Author Spotlight: Investigating Bacteriophage-Induced Immune Responses in Gnotobiotic Mice

Author Spotlight: Investigating Bacteriophage-Induced Immune Responses in Gnotobiotic Mice

Published on: January 26, 2024

Area of Science:

Microbiology
Bacteriology
Virology

Background:

Commensal bacteria can contribute to disease development.
Bacteriophages are viruses that specifically infect bacteria.
Targeting commensal bacteria is a potential therapeutic strategy.

Purpose of the Study:

To investigate the potential of bacteriophages as agents to suppress disease-contributing commensal bacteria.
To explore bacteriophage therapy for managing bacterial populations linked to health issues.

Main Methods:

Literature review on bacteriophage-host interactions.
Analysis of existing studies on bacteriophage efficacy against commensal bacteria.
Identification of specific bacteriophage-commensal bacterial relationships.

Main Results:

Bacteriophages demonstrate specificity in targeting and reducing populations of certain commensal bacteria.
Evidence suggests bacteriophages can disrupt bacterial communities associated with disease states.
Phage therapy presents a viable approach to modulate detrimental commensal bacteria.

Conclusions:

Bacteriophages are effective biological agents for suppressing disease-associated commensal bacteria.
Phage-based interventions offer a promising avenue for novel therapeutic strategies in infectious diseases and microbiome-related disorders.